Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

83.13
Delayed Data
As of May 22
 -1.76 / -2.07%
Today’s Change
32.36
Today|||52-Week Range
85.93
+89.45%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close84.89
Today’s open84.99
Day’s range82.55 - 85.79
Volume364,273
Average volume (3 months)365,810
Market cap$3.0B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-14.12%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.35

Competitors

 Today’s
change
Today’s
% change
WXWuXi PharmaTech (Cay...-0.13-0.30%
CLVSClovis Oncology Inc+0.23+0.25%
ANACAnacor Pharmaceutica...+1.94+3.06%
CBPOChina Biologic Produ...+1.37+1.27%
Data as of 4:02pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior Vice President &
Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers